Evidence map›Paper›PMID 39021546›Full record

ArticleEcancermedicalscience2024

Survival trends in gastric cancer in Brazil: real-life data from a large cancer center.

Angelo Borsarelli Carvalho Brito, Tiago Cordeiro Felismino, Diego Rodrigues Mendonca E Silva, Maria Paula Curado, Lais Corsino Durant, Rodrigo Gomes Taboada, Adriane Graicer Pelosof, Alessandro Landskron Diniz, Felipe Jose Fernandez Coimbra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ecancermedicalscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angelo Borsarelli Carvalho BritoDepartment of Clinical Oncology, A. C. Camargo Cancer Center, Sao Paulo 01509-010, Brazil.
Tiago Cordeiro FelisminoDepartment of Clinical Oncology, A. C. Camargo Cancer Center, Sao Paulo 01509-010, Brazil.
Diego Rodrigues Mendonca E SilvaHospital Cancer Registry, A.C. Camargo Cancer Center, São Paulo 01509-010, Brazil.
Maria Paula CuradoHospital Cancer Registry, A.C. Camargo Cancer Center, São Paulo 01509-010, Brazil.
Lais Corsino DurantDepartment of Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo 01509-010, Brazil.
Rodrigo Gomes TaboadaDepartment of Clinical Oncology, A. C. Camargo Cancer Center, Sao Paulo 01509-010, Brazil.
Adriane Graicer PelosofDepartment of Endoscopy, A. C. Camargo Cancer Center, São Paulo 01509-010, Brazil.
Alessandro Landskron DinizDepartment of Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo 01509-010, Brazil.
Felipe Jose Fernandez CoimbraDepartment of Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo 01509-010, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) is the fourth leading cause of cancer deaths globally. There is a paucity of real-life data on GC in Brazil. Our study aimed to evaluate survival trends in gastric adenocarcinoma (GA) in a large cancer center in Brazil during 2000-2017. Methods: Based on our Hospital Cancer Registry Database, all individuals diagnosed with GA between 2000 and 2017, and treated at A.C. Camargo Cancer Center, were retrospectively included. The primary objectives were to describe the patient demographics, clinicopathological characteristics, treatment modalities and survival trends during four separate periods of diagnosis (2000-2004; 2005-2009; 2010-2014 and 2015-2017). Results: This analysis included 1,406 individuals. Across all periods, most patients were men aged 50-69 and presented with Lauren's intestinal subtype. The frequency of stage IV disease significantly decreased between 2000-2004 and 2015-2017 (43.6% to 32.8%, Conclusion: Our retrospective cohort showed an upward trend in survival rates during the period. We observed that 5-year OS almost doubled among men and women during 2000-2017. Mini Abstract: The present retrospective cohort showed an upward trend in survival rates during the period from 2000 to 2017, in which the OS almost doubled among men and women.

Indexed as

epidemiologygastric cancerprognosis

Identifiers

PMID39021546
PMCPMC11254403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.